US · Healthcare · Biotechnology
EPS came in at -0.16 against a street estimate of -0.14 — a miss of 14.3%.
Analysts rate Savara Inc a strong buy (9 buy, 0 hold, 0 sell out of 9) with an average price target of $11.06.
| Fund | Stake |
|---|---|
| NEA Management Company, LLC | 11.91% |
| Bain Capital Life Sciences Investors, LLC | 8.57% |
| VR Adviser, LLC | 7.18% |
| Nantahala Capital Management, LLC | 6.79% |
| Deerfield Management Co | 6.60% |
| BlackRock Inc | 6.08% |
| TCG Crossover Management, LLC | 6.02% |
| Frazier Life Sciences Management, L.P. | 4.73% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 SAVARA INC. – 10-Q SUMMARY (Q2 2026) HEADLINE NUMBERS • Cash position: $41.8 million cash + $131.2 million short-term investments = $173 million tot | 2026-08-11 |
| Board / officer change · Q2 2026 SAVARA INC. (SVRA) - 8-K SUMMARY HEADLINE NUMBERS • Stockholders approved increase in authorized common stock shares from 300,000,000 to 600,000,000 | 2026-06-08 |
| Quarterly report · Q1 2026 SAVARA INC. - 10-Q SUMMARY FOR Q1 2026 HEADLINE NUMBERS • Cash and investments: $38.8 million cash + $164.0 million short-term investments = $202.8 | 2026-05-12 |
| Proxy statement · Q2 2026 SAVARA INC. PROXY STATEMENT SUMMARY CEO COMPENSATION • Matthew Pauls (CEO and Chair): Total 2025 compensation was $3,455,788 • This consists of: $500 | 2026-04-24 |
| Annual report FY2025 SAVARA INC. – 10-K SUMMARY FOR RETAIL INVESTORS --- HEADLINE NUMBERS • Company: Savara Inc. (ticker: SVRA, Nasdaq) • Market cap (as of June 30, 202 | 2026-03-13 |
| Material agreement · Q1 2026 SAVARA INC. (SVRA) - 8-K FILING SUMMARY March 10, 2026 --- BUSINESS & SEGMENT HIGHLIGHTS • Savara Inc. is a biopharmaceutical company (ticker: SVRA | 2026-03-13 |
| Material agreement · Q1 2026 SAVARA INC. (SVRA) - 8-K SUMMARY HEADLINE NUMBERS • Total borrowing capacity under amended Loan and Security Agreement: $105 million in term loans • | 2026-01-27 |
| Reg FD disclosure · Q1 2026 SAVARA INC. (SVRA) - 8-K SUMMARY HEADLINE NUMBERS • Filing Date: January 9, 2026 • Company: Savara Inc., a Delaware corporation • Stock Symbol: SVRA | 2026-01-09 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Savara Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.